Akèy › Kadiyomiopati Ipertrofik › Michigan
Etid klinik pou Kadiyomiopati Ipertrofik nan Michigan
3 etid pou Kadiyomiopati Ipertrofik ap chèche patisipan nan sit nan Michigan.
Tèks ofisyèl etid la (Anglè)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Spectrum Health Medical Group, Grand Rapids
- Henry Ford Health System, West Bloomfield
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Grand Rapids
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT07023614HCMR Re-Imaging Study
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou Mar 18, 2026 · NCT07054073Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.